JAK1 Pathway Inhibitors for the Treatment of Gastrointestinal Disease
Copyright © Targeted News Service 2024
2024-11-26
ALEXANDRIA, Virginia, Nov. 26 -- INCYTE CORPORATION, Wilmington, Delaware has been assigned a patent (No. US 12150943 B2, initially filed Jan. 31, 2023) developed by three inventors Krishnaswamy Yeleswaram, Landenberg, Pennsylvania; Paul Smith, Carlsbad, California; and Gregory F. Hollis, Wilmington, Delaware, for "JAK1 pathway inhibitors for the treatment of gastrointestinal disease." . . .